Table 1.

LUAD clinical cohort characteristics

CharacteristicPROSPECT (N = 93), n (%)TCGA (N = 181), n (%)
Female38 (41)105 (58)
Male55 (59)76 (42)
Stage I48 (52)95 (52)
Stage II26 (28)39 (22)
Stage III19 (20)40 (22)
Stage IV7 (4)
Adjuvant chemotherapy40 (43)
No adjuvant chemotherapy53 (57)
Smoking
 Never8 (9)27 (15)
 Former49 (52)111 (62)
 Current36 (39)35 (19)
 Unknown8(4)
K-Ras
 Mutant26 (28)47 (26)
 Nonmutant64 (69)134 (74)
 Unknown3 (3)
EGFR
 Mutant5 (5)27 (15)
 Nonmutant50 (54)154 (85)
 Unknown38 (41)
BRAF
 Mutant0 (0)13 (7)
 Nonmutant77 (82)168 (93)
 Unknown9 (10)
PIK3CA
 Mutant7 (8)13 (7)
 Nonmutant77 (82)168 (93)
 Unknown9 (10)